Obesity
Conditions
Interventions
This is a two-arm, double-blind, randomized controlled clinical study. A total of 120 people who meet the eligibility criteria will be randomly allocated to a placebo group or another intervention gro
G07.203.300.456
Sponsors
Universidade Federal do Piauí
Universidade Federal do Piauí
Eligibility
Age
20 Years to 39 Years
Inclusion criteria
Inclusion criteria: Healthy volunteers; body mass index between 25 and 29.9 kg/m²; age range between 20 and 39 years; non-smokers; non-alcoholics; both sexes
Exclusion criteria
Exclusion criteria: With comorbidities and/or complications such as kidney, liver, severe cardiovascular and gastrointestinal diseases; who use continuous medications (except contraceptives); allergy to any food ingredient used; women who are pregnant or lactating; individuals who drink alcohol or smoke; people who take fiber supplements or undergo weight loss treatments; individuals who perform moderate or high intensity physical activity for more than 30 minutes daily; individuals who present cognitive alterations, such as psychotic disorder resulting from a general medical condition and/or induced by substances, Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, Brief Psychotic Disorder, Delusional Disorder and Psychotic Disorder without specification
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to observe a reduction in body weight and an improvement in the metabolic profile, assessed by bioimpedance and blood tests. Data collected at the beginning and end of the intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Increased intestinal motility, inhibition of hunger and increased satiety are expected. | — |
Countries
Brazil
Contacts
Public ContactCíntia Reis
Universidade Federal do Piauí
Outcome results
None listed